CSL Executive and Leadership Team

Ken Lim, the Chief Financial Officer at CSL, directs all global fiscal operations and capital allocation strategies. Overseeing the financial health of the biotechnology portfolio, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the development of lifesaving medicines. This leadership role involves managing complex investment cycles for iron deficiency and nephrology therapies. By optimizing resource distribution across the organization, Ken Lim directly impacts the long-term sustainability of the company. Ultimately, Lim secures the necessary funding to advance research initiatives, ensuring the enterprise maintains a competitive edge in the global health services market while delivering consistent value to stakeholders through disciplined financial oversight and strategic planning.

Jody Long, the Administrative Advisor To Chief Financial Officer at CSL, directs the operational workflow and strategic support for the finance department. Overseeing the coordination of executive meetings and financial reporting schedules, the Administrative Advisor To Chief Financial Officer ensures that the leadership team remains focused on core fiscal objectives. This role involves managing the flow of critical information between the finance office and other corporate divisions. By streamlining administrative processes, Jody Long enhances the efficiency of the financial planning and analysis functions. Long provides essential support for the execution of long-term capital strategies, ensuring that the company maintains its financial stability while pursuing ambitious growth targets in the global biotechnology market through meticulous organization and proactive management.

Emiliano Chiaramonte, the Chief Financial Officer, LATAM (South) at CSL, directs all financial operations and fiscal strategy within the southern Latin American region. Overseeing the management of regional budgets and investment portfolios, the Chief Financial Officer, LATAM (South) ensures that the company maintains a strong economic presence in this critical market. This role involves navigating complex regulatory environments to support the distribution of lifesaving therapies. By optimizing local financial performance, Emiliano Chiaramonte contributes to the overall growth of the enterprise. Chiaramonte manages regional financial risks and identifies opportunities for expansion, ensuring that the company remains well-positioned to deliver its portfolio of medicines to patients across the region while maintaining strict fiscal discipline and operational transparency.

Ruby Eappen, the Global Quality Manager, Supplier & Chief Marketing Officer at CSL, architects the standards for supply chain integrity and market positioning. Overseeing the quality assurance protocols for critical biotechnology components, the Global Quality Manager, Supplier & Chief Marketing Officer ensures that every therapeutic product meets stringent safety requirements. This role involves aligning marketing strategies with quality benchmarks to maintain trust in the global healthcare sector. By integrating supplier performance metrics with brand outreach, Ruby Eappen drives operational excellence across the entire product lifecycle. Eappen manages the intersection of regulatory compliance and market growth, ensuring that the company delivers reliable, high-quality vaccines and therapies to patients worldwide while upholding the highest standards of corporate responsibility and operational precision.

Amanda Taylor, the Chief Marketing Officer, Campaign & Manager (Americas) at CSL, directs all regional outreach and commercial growth initiatives across the Americas. Overseeing the execution of complex campaigns for hemophilia and immune deficiency treatments, the Chief Marketing Officer, Campaign & Manager (Americas) ensures that healthcare providers receive accurate information regarding the latest biotechnology advancements. This leadership role involves coordinating with regional sales teams to expand market access for critical therapies. By analyzing patient needs and market trends, Amanda Taylor optimizes the delivery of lifesaving medicines to diverse populations. Taylor strengthens the company's presence in the region through targeted communication strategies, ensuring that the organization remains the preferred partner for medical professionals seeking effective, technology-driven solutions for chronic health conditions.

Phyllis Post, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T at CSL, architects the digital infrastructure supporting global research and manufacturing. Overseeing the integration of information technology across multiple business units, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T ensures that data systems remain secure and scalable. This role involves implementing advanced analytics to accelerate the development of vaccines and therapies. By modernizing the technological backbone of the enterprise, Phyllis Post enables seamless collaboration between global teams. Post drives digital transformation initiatives that enhance operational efficiency, ensuring that the company leverages cutting-edge technology to maintain its leadership position in the biotechnology industry while protecting sensitive research data and patient information.

Candice Nieves, the Manager Chief Marketing Officer Quality at CSL, directs the quality control processes within the marketing department to ensure brand consistency and regulatory adherence. Overseeing the alignment of promotional materials with clinical data, the Manager Chief Marketing Officer Quality ensures that all communications accurately reflect the efficacy of the company's lifesaving medicines. This role involves auditing marketing campaigns to verify compliance with global health standards. By maintaining high quality benchmarks, Candice Nieves supports the integrity of the company's brand in the competitive biotechnology landscape. Nieves facilitates cross-functional collaboration between marketing and regulatory teams, ensuring that all outreach efforts remain transparent and scientifically grounded, ultimately fostering trust among healthcare providers and patients who rely on the company's innovative therapeutic solutions.

Hamza Shanaa, the Manager Chief Marketing Officer Quality at CSL, directs the quality assurance frameworks for marketing initiatives to ensure precision in global messaging. Overseeing the validation of clinical claims within promotional content, the Manager Chief Marketing Officer Quality ensures that all marketing activities align with the company's commitment to scientific excellence. This role involves monitoring the impact of marketing campaigns on market perception and regulatory compliance. By implementing rigorous quality standards, Hamza Shanaa protects the reputation of the company's therapeutic portfolio. Shanaa coordinates with internal stakeholders to refine communication strategies, ensuring that the organization effectively conveys the value of its lifesaving medicines to global audiences while maintaining strict adherence to industry regulations and ethical marketing practices.

Eric McKay, the Regional Category Manager & Chief Marketing Officer, Research & Development at CSL, directs the strategic alignment of research initiatives with market demand. Overseeing the development of commercial strategies for new therapies, the Regional Category Manager & Chief Marketing Officer, Research & Development ensures that the company's innovation pipeline addresses unmet patient needs. This role involves bridging the gap between laboratory research and commercialization. By analyzing market trends, Eric McKay guides the prioritization of R&D projects to maximize therapeutic impact. McKay coordinates with global teams to ensure that new products reach the market efficiently, driving the company's mission to save lives through advanced biotechnology while maintaining a focus on sustainable growth and long-term medical advancement.

Amy Van Buren, the Chief People Officer at CSL, directs the global human resources strategy and organizational development initiatives. Overseeing the recruitment, retention, and professional growth of the company's diverse workforce, the Chief People Officer ensures that the enterprise attracts top talent to support its biotechnology mission. This role involves fostering a culture of innovation and inclusivity across all global operations. By implementing comprehensive talent management programs, Amy Van Buren drives employee engagement and operational performance. Van Buren aligns human capital strategies with the company's long-term business goals, ensuring that the organization possesses the necessary expertise to continue developing lifesaving medicines while maintaining a supportive and high-performing work environment for all employees worldwide.